Aimei Health Technology Co., Ltd (AFJK)
NASDAQ: AFJK · Real-Time Price · USD
10.52
-0.08 (-0.75%)
Dec 20, 2024, 4:00 PM EST - Market closed

Company Description

Aimei Health Technology Co., Ltd does not have significant operations.

It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities.

It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors.

Aimei Health Technology Co., Ltd was incorporated in 2023 and is based in New York, New York.

Aimei Health Technology Co., Ltd
Aimei Health Technology logo
Country United States
Founded 2023
IPO Date Dec 4, 2023
Industry Shell Companies
Sector Financials
CEO Junheng Xie

Contact Details

Address:
10 East 53rd Street, Suite 3001
New York, New York 10022
United States
Phone 212 845 9945

Stock Details

Ticker Symbol AFJK
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $10.00
CIK Code 0001979005
ISIN Number KYG013411098
SIC Code 6770

Key Executives

Name Position
Junheng Xie Chief Executive Officer, Secretary and Director
Heung Ming Wong Chief Financial Officer and Director

Latest SEC Filings

Date Type Title
Dec 13, 2024 8-K Current Report
Dec 3, 2024 DEF 14A Other definitive proxy statements
Nov 21, 2024 PRE 14A Other preliminary proxy statements
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 14, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 10-Q Quarterly Report
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Nov 13, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Oct 16, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Aug 9, 2024 10-Q Quarterly Report